Trial Condition(s):

Hypertension

Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®

Bayer Identifier:

13599

ClinicalTrials.gov Identifier:

NCT00927537

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The efficacy and tolerability of an antihypertensive treatment with Telmisartan is followed over 3-4 months

Inclusion Criteria
- Hypertensive patients seen by the physician requiring antihypertensive treatment
Exclusion Criteria
- According to the local drug information

Trial Summary

Enrollment Goal
2052
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Kinzal/Pritor (Telmisartan, BAY68-9291)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Switzerland

Status
Completed
 

Trial Design